Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-14-000659
Filing Date
2014-05-14
Accepted
2014-05-14 16:47:55
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 SIGNPATH PHARMA INC. 10Q 2014-03-31 signpath.htm 10-Q 757790
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN signpathexh31.htm EX-31.1 15956
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN signpathexh32.htm EX-32.1 8600
  Complete submission text file 0001096906-14-000659.txt   4943146

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT sppxbrl-20140331.xml EX-101.INS 1039184
5 XBRL SCHEMA DOCUMENT sppxbrl-20140331.xsd EX-101.SCH 30377
6 XBRL CALCULATION LINKBASE DOCUMENT sppxbrl-20140331_cal.xml EX-101.CAL 13961
7 XBRL DEFINITION LINKBASE DOCUMENT sppxbrl-20140331_def.xml EX-101.DEF 41522
8 XBRL LABELS LINKBASE DOCUMENT sppxbrl-20140331_lab.xml EX-101.LAB 124301
9 XBRL PRESENTATION LINKBASE DOCUMENT sppxbrl-20140331_pre.xml EX-101.PRE 108879
Mailing Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951
Business Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951 267-772-0107
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-158474 | Film No.: 14842152
SIC: 2834 Pharmaceutical Preparations